ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ALTH Allos Therapeutics, Inc. (MM)

1.83
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Allos Therapeutics, Inc. (MM) NASDAQ:ALTH NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.83 0 01:00:00

Global Market Perspective Review on ALTH, CINF, ALKS, DBRN, APOL and INFY from TheFortuneFinancial.com

02/11/2009 10:12am

Marketwired


Allos Therapeutics, Inc. (MM) (NASDAQ:ALTH)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Allos Therapeutics, Inc. (MM) Charts.

TheFortuneFinancial.com provides the highest level of independent research and investment strategies with the sole purpose of consistently identifying stocks that provide the biggest return on investment for our subscribers. Investors seeking free and unbiased analyst opinions on the companies mentioned in this release are encouraged to register at http://www.thefortunefinancial.com/ for a free subscription to access these reports.

Today, we have asked some of the top analysts worldwide to give us their updated feedback regarding the current market activity and position on Allos Therapeutics Inc. (NASDAQ: ALTH), Cincinnati Financial Corp. (NASDAQ: CINF), Alkermes Inc. (NASDAQ: ALKS), Dress Barn Inc. (NASDAQ: DBRN), Apollo Group Inc. (NASDAQ: APOL) and Infosys Technologies Limited (NASDAQ: INFY).

To have free access to these analyst opinions, sign up now to www.thefortunefinancial.com by clicking the link below. We have other reports that could be of interest to you and they are free of charge with no strings attached.

http://www.thefortunefinancial.com/

All analyst reviews will be posted for free under "today's articles" within 24 hours they are advertized online.

Each interview will vary and may include, but will not be limited to the following:

-  An Unbiased View of the Company
-  Short-term Target Prices
-  Long-term Resistance and Support Levels
-  Analyst Opinions
-  Sector Review
-  Competition Overview

Investors looking to access these analytical opinions and reports are encouraged to sign up now at http://www.thefortunefinancial.com/

Being a member with www.thefortunefinancial.com gives the unique opportunity to receive a free "custom stock review" on any large cap equity you currently hold in your portfolio. Simply sign up for your free membership today, and in the members section of www.thefortunefinancial.com, you can submit your stock review to an analyst for his or her opinion of any stocks you currently following by filling out the form under the tab "request a stock review."

TheFortuneFinancial.com is not affiliated or compensated by any of the above mentioned companies, nor do we own a position in any of the companies.

NASDAQ:ALTH NASDAQ:ALKS NASDAQ:CINF NASDAQ:DBRN NASDAQ:APOL NASDAQ:INFY

1 Year Allos Therapeutics, Inc. (MM) Chart

1 Year Allos Therapeutics, Inc. (MM) Chart

1 Month Allos Therapeutics, Inc. (MM) Chart

1 Month Allos Therapeutics, Inc. (MM) Chart

Your Recent History

Delayed Upgrade Clock